A double-blind, multinational, multicenter, randomised, 2-period crossover study to assess
the efficacy and safety of advanced closed-loop insulin delivery with Minimed 670G 4.0 system
comparing Faster Insulin Aspart to Standard Insulin Aspart therapy over 4 weeks in active
children and adolescents with type 1 diabetes.
Phase:
N/A
Details
Lead Sponsor:
University of Ljubljana, Faculty of Medicine
Collaborators:
Medical University of Graz Department of Pediatrics and Adolescent Medicine, Graz, Austria UMC Ljubljana University Children's Hospital Ljubljana